Evidence map›Paper›PMID 22517773›Full record

ArticleAmerican journal of physiology. Gastrointestinal and liver physiology2012

Impaired ghrelin signaling is associated with gastrointestinal dysmotility in rats with gastroesophageal reflux disease.

Miwa Nahata, Shuichi Muto, Nobuhiko Oridate, Shunsuke Ohnishi, Koji Nakagawa, Chiharu Sadakane, Yayoi Saegusa, Tomohisa Hattori, Masahiro Asaka, Hiroshi Takeda

Abstract read
In one paragraph

Article in American journal of physiology. Gastrointestinal and liver physiology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 46 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Therapeutic Potential of Targeting the Ghrelin Pathway.International journal of molecular sciences · 2017
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Electroacupuncture Stimulation at CV12 Inhibits Gastric Motility via TRPV1 Receptor.Evidence-based complementary and alternative medicine : eCAM · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Miwa NahataDept. of Pathophysiology and Therapeutics, Division of Pharmasciences, Faculty of Pharmaceutical Sciences, Hokkaido University, Kita-ku, Sapporo, Hokkaido, Japan. h_takeda@pharm.hokudai.ac.jp
Shuichi Muto
Nobuhiko Oridate
Shunsuke Ohnishi
Koji Nakagawa
Chiharu Sadakane
Yayoi Saegusa
Tomohisa Hattori
Masahiro Asaka
Hiroshi Takeda
Hokkaido University · JPTsumura Research Institute (Japan) · JPGeneral Department of Preventive Medicine · VNHokkaido Pharmaceutical University · JPNational Institute of Technology, Tomakomai College · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gastroesophageal reflux disease (GERD) is often associated with decreased upper gastrointestinal motility, and ghrelin is an appetite-stimulating hormone known to increase gastrointestinal motility. We investigated whether ghrelin signaling is impaired in rats with GERD and studied its involvement in upper gastrointestinal motility. GERD was induced surgically in Wistar rats. Rats were injected intravenously with ghrelin (3 nmol/rat), after which gastric emptying, food intake, gastroduodenal motility, and growth hormone (GH) release were investigated. Furthermore, plasma ghrelin levels and the expression of ghrelin-related genes in the stomach and hypothalamus were examined. In addition, we administered ghrelin to GERD rats treated with rikkunshito, a Kampo medicine, and examined its effects on gastroduodenal motility. GERD rats showed a considerable decrease in gastric emptying, food intake, and antral motility. Ghrelin administration significantly increased gastric emptying, food intake, and antral and duodenal motility in sham-operated rats, but not in GERD rats. The effect of ghrelin on GH release was also attenuated in GERD rats, which had significantly increased plasma ghrelin levels and expression of orexigenic neuropeptide Y/agouti-related peptide mRNA in the hypothalamus. The number of ghrelin-positive cells in the gastric body decreased in GERD rats, but the expression of gastric preproghrelin and GH secretagogue receptor mRNA was not affected. However, when ghrelin was exogenously administered to GERD rats treated with rikkunshito, a significant increase in antral motility was observed. These results suggest that gastrointestinal dysmotility is associated with impaired ghrelin signaling in GERD rats and that rikkunshito restores gastrointestinal motility by improving the ghrelin response.

Indexed as

Agouti-Related ProteinAnimalsDrugs, Chinese HerbalDuodenumEatingGastric EmptyingGastroesophageal RefluxGastrointestinal MotilityGhrelinGrowth HormoneImmunohistochemistryMaleNeuropeptide YPlant ExtractsPolymerase Chain ReactionRatsAgouti-Related ProteinDrugs, Chinese HerbalGhrelinGrowth Hormoneliu-jun-zi-tangNeuropeptide YPlant ExtractsRNA

Identifiers

PMID22517773
PMCPMC3404573
OpenAlexW2151306905

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.